semaglutide product information Ozempic® Pen Dosing Ozempic (semaglutide): Uses, Side Effects,

The scientists behind these discoveries could be among the 2025 Nobel Prize winners.

Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and cardiovascular disease (the most common cause of mortality in diabetes), as well as microvascular complications such as kidney disease and retinopathy

In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses the top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs.

Reports from Q4 2003 to Q1 2024 were analyzed using the OpenVigil 2.1 platform to identify male patients experiencing orgasmic dysfunction, erectile dysfunction, or decreased libido linked to GLP-1 receptor agonists (tirzepatide, semaglutide, dulaglutide, exenatide, lixisenatide, and liraglutide)

The next decade could determine which companies emerge as the dominant players in metabolic health

Find out if GLP-1 drugs is covered by Blue Cross Blue Shield of North Carolina, typical copay ranges, prior-auth rules, and affordable alternatives